Correlation Between Eterna Therapeutics and Dyne Therapeutics

Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eterna Therapeutics and Dyne Therapeutics, you can compare the effects of market volatilities on Eterna Therapeutics and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Dyne Therapeutics.

Diversification Opportunities for Eterna Therapeutics and Dyne Therapeutics

0.68

Correlation Coefficient

Eterna Therapeutics  Dyne Therapeutics

Poor diversification

The 3 months correlation between Eterna and Dyne is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Dyne Therapeutics go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Dyne Therapeutics

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Dyne Therapeutics. In addition to that, Eterna Therapeutics is 1.88 times more volatile than Dyne Therapeutics. It trades about -0.28 of its total potential returns per unit of risk. Dyne Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest  3,641  in Dyne Therapeutics on September 19, 2024 and sell it today you would lose (1,025) from holding Dyne Therapeutics or give up 28.15% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Eterna Therapeutics  vs.  Dyne Therapeutics

Eterna Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Dyne Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Eterna Therapeutics and Dyne Therapeutics

The main advantage of trading using opposite Eterna Therapeutics and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.

The idea behind Eterna Therapeutics and Dyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.